Niagen Bioscience (NAGE) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Niagen Bioscience (NAGE) over the last 14 years, with Q3 2025 value amounting to $27.5 million.
- Niagen Bioscience's Total Liabilities rose 2396.97% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 2396.97%. This contributed to the annual value of $22.2 million for FY2024, which is 1631.21% down from last year.
- Latest data reveals that Niagen Bioscience reported Total Liabilities of $27.5 million as of Q3 2025, which was up 2396.97% from $27.3 million recorded in Q2 2025.
- Niagen Bioscience's 5-year Total Liabilities high stood at $27.5 million for Q3 2025, and its period low was $22.2 million during Q3 2024.
- For the 5-year period, Niagen Bioscience's Total Liabilities averaged around $25.3 million, with its median value being $25.8 million (2022).
- In the last 5 years, Niagen Bioscience's Total Liabilities plummeted by 1631.21% in 2024 and then soared by 2396.97% in 2025.
- Quarter analysis of 5 years shows Niagen Bioscience's Total Liabilities stood at $26.1 million in 2021, then dropped by 2.79% to $25.4 million in 2022, then grew by 4.42% to $26.5 million in 2023, then fell by 16.31% to $22.2 million in 2024, then increased by 23.8% to $27.5 million in 2025.
- Its last three reported values are $27.5 million in Q3 2025, $27.3 million for Q2 2025, and $26.0 million during Q1 2025.